4//SEC Filing
Edge Therapeutics, Inc. 4
Accession 0001127602-17-009471
$PDSBCIK 0001472091operating
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 10:57 AM ET
Size
5.2 KB
Accession
0001127602-17-009471
Insider Transaction Report
Form 4
Wyant Alyssa
SVP Regulatory Affairs
Transactions
- Award
Stock Option (right To Purchase)
2017-03-01$9.81/sh+80,000$784,800→ 80,000 totalExercise: $9.81Exp: 2027-02-28→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 80,000 shares of Common Stock, will become exercisable on February 21, 2018, with a 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001472091
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 10:57 AM ET
- Size
- 5.2 KB